Adage Capital Partners Gp, L.L.C. Chinook Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
Shares
5 transactions
Others Institutions Holding KDNY
# of Institutions
3Shares Held
234KCall Options Held
0Put Options Held
0About CHINOOK THERAPEUTICS, INC.
- Ticker KDNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,896,300
- Description
- Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...